Sutro Biopharma (STRO) Net Margin Growth (5y) (2022 - 2025)

Sutro Biopharma (STRO) Net Margin Growth (5y) (2022 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn
7 Belite Bio 61.40 Bn 61.40 Bn -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn -
10 Sutro Biopharma 192.86 Mn 51.43 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 -39,688.00
Sep 30, 2025 -30,928.00
Jun 30, 2025 18,249.00
Mar 31, 2025 -11,469.00
Dec 31, 2024 -33,507.00
Sep 30, 2024 -46,745.00
Jun 30, 2024 -4,406.00
Mar 31, 2024 -28,238.00
Dec 31, 2023 3,513.00
Sep 30, 2023 -5,910.00
Jun 30, 2023 -16,766.00
Mar 31, 2023 -18,667.00
Dec 31, 2022 -2,002.00
Sep 30, 2022 -7,042.00